Scotia Capital Inc. Abb Vie Inc. Transaction History

Scotia Capital Inc.

$17.8 Billion
Q3 2024

A detailed history of Scotia Capital Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Scotia Capital Inc. holds 137,486 shares of ABBV stock, worth $24.1 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

137,486

Previous 155,449 11.56%

Holding current value

$24.1 Million

Previous $26.7 Million 1.83%

% of portfolio

0.15%

Previous 0.16%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $2.94 Million - $3.58 Million	-17,963 Reduced 11.56%	137,486 $27.2 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $158,969 - $185,640	-1,027 Reduced 0.66%	155,449 $26.7 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $165,573 - $188,655	1,036 Added 0.67%	156,476 $28.5 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $978,473 - $1.1 Million	7,111 Added 4.79%	155,440 $24.1 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $99,524 - $115,214	745 Added 0.5%	148,329 $22.1 Million
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $5.7 Million - $7.1 Million	-43,033 Reduced 22.58%	147,584 $19.9 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $291,533 - $335,744	2,016 Added 1.07%	190,617 $30.4 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $551,303 - $661,157	3,986 Added 2.16%	188,601 $30.5 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $1.87 Million - $2.14 Million	-13,897 Reduced 7.0%	184,615 $24.8 Million
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $658,649 - $837,358	4,786 Added 2.47%	198,512 $30.4 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $5.61 Million - $6.96 Million	-42,485 Reduced 17.99%	193,726 $31.4 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $3.53 Million - $4.47 Million	32,898 Added 16.18%	236,211 $32 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $1.42 Million - $1.62 Million	13,379 Added 7.04%	203,313 $21.9 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $3.41 Million - $3.8 Million	-32,415 Reduced 14.58%	189,934 $21.4 Million
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $1.02 Million - $1.12 Million	9,964 Added 4.69%	222,349 $24.1 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $851,664 - $1.15 Million	10,581 Added 5.24%	212,385 $22.8 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $3.76 Million - $4.41 Million	43,764 Added 27.69%	201,804 $17.7 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $4.75 Million - $6.36 Million	64,729 Added 69.37%	158,040 $15.5 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $1.28 Million - $1.95 Million	19,891 Added 27.09%	93,311 $7.11 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $2.43 Million - $3.04 Million	-33,739 Reduced 31.48%	73,420 $6.5 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $1.7 Million - $2.05 Million	-27,062 Reduced 20.16%	107,159 $8.11 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $1.62 Million - $2.08 Million	24,731 Added 22.59%	134,221 $9.76 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $692,331 - $814,840	8,975 Added 8.93%	109,490 $8.82 Million
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $917,384 - $1.13 Million	11,784 Added 13.28%	100,515 $9.27 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $495,406 - $550,736	-5,572 Reduced 5.91%	88,731 $8.39 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $139,069 - $164,550	1,549 Added 1.67%	94,303 $8.85 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $3.09 Million - $4.13 Million	-33,543 Reduced 26.56%	92,754 $8.78 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $163,447 - $179,233	1,825 Added 1.47%	126,297 $12.2 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $91,433 - $116,788	1,309 Added 1.06%	124,472 $11.1 Million
Q2 2017 Aug 15, 2017	BUY	N/A	123,163	123,163 $8.93 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Abb Vie Inc. Transaction History